CureVac
Thaminda Ramanayake is a seasoned professional in business development and strategic advisory roles within the biotechnology and pharmaceutical sectors. Currently serving as Chief Business Officer at CureVac since June 2024, Thaminda also provides strategic advice at CatAIlyst Inc. Thaminda has held significant positions including Chief Business Officer at Affini-T Therapeutics and Vice President, Global Head of Business Development in Oncology at Sanofi. Previous roles also include senior positions at BioMarin Pharmaceutical Inc. and Amgen with a strong focus on deal structuring and negotiations, corporate strategy, and transaction execution. Additionally, Thaminda has contributed to the Youth Science Center as Director of the Board and has provided strategic advisory services to several companies such as Allievex Corporation and AceLink Therapeutics. Thaminda holds an MBA in Finance from the University of Rochester and advanced degrees in Immunology and Biological Science.
This person is not in any teams
This person is not in any offices
CureVac
7 followers
CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes. The principle of CureVac’s proprietary technology is the use of non-chemically modified mRNA as a data carrier to instruct the human body to produce its own proteins capable of fighting a broad range of diseases.